CONSOLIDATED STATEMENT OF OPERATIONS (USD $)	12 Months Ended		86 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
Income Statement [Abstract]
REVENUES
COST AND EXPENSES
Research and Development	17,715	51,286	1,272,886
General and Administrative	564,479	550,769	6,670,301
Depreciation and Amortization			2,668
Consulting and Professional Fees	213,232	63,692	5,023,946
Impairment of Goodwill and Intangibles			34,688
Total Costs and Expenses	795,426	665,747	13,004,489
OPERATING LOSS	(795,426)	(665,747)	(13,004,489)
OTHER INCOME & (EXPENSES)
Interest Expense	(55,139)	(62,829)	(413,674)
Loss on Early Extinguishment of Debt	(41,688)		(41,688)
Interest Expense attributable to amortization of discount	(374,338)		(374,338)
Interest Income			306
Securities issued pursuant to contractual obligations	(66,372)		(66,372)
Other Income	25	146,791	176,916
Gain on de-consolidation of subsidiary		42,182,649	42,182,649
Loss on sale of Available for Sale Securities			(487,900)
Loss on disposal of Equipment	20,789	510,782	531,571
Other Expense			(166)
Other Losses attributable to subsidiary		(228,713)	(228,713)
Total Other Income & (Expense)	(558,301)	41,527,116	40,215,449
NET INCOME (LOSS)	(1,353,727)	40,861,369	27,210,960
(Net Income) Loss attributable to noncontrolling interest		229,845	536,961
NET INCOME (LOSS) before equity in losses of Entest	(1,353,727)	41,091,214	27,747,921
Equity in Net Income (Loss) of Entest	(399,082)	(264,567)	(663,649)
NET INCOME (LOSS) attributable to common shareholders	$ (1,752,809)	$ 40,826,647	$ 27,084,272
BASIC AND FULLY DILUTED EARNINGS (LOSS)	$ (0.01)	$ 0.57
Weighted average number of shares outstanding	148,749,547	72,071,414